Dr. Stuart Ginther, M.D

NPI: 1194776799
Total Payments
$1,855
2024 Payments
$150.19
Companies
26
Transactions
114
Medicare Patients
25,175
Medicare Billing
$1.2M

Payment Breakdown by Category

Food & Beverage$1,793 (96.7%)
Education$61.57 (3.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,793 112 96.7%
Education $61.57 2 3.3%

Top Paying Companies

Company Total Records Latest Year
Otsuka America Pharmaceutical, Inc. $336.35 18 $0 (2024)
AstraZeneca Pharmaceuticals LP $283.75 15 $0 (2024)
OPKO Pharmaceuticals, LLC $210.01 16 $0 (2022)
Relypsa, Inc. $176.13 12 $0 (2020)
Amgen Inc. $129.49 8 $0 (2024)
Bayer Healthcare Pharmaceuticals Inc. $106.22 6 $0 (2023)
Mallinckrodt LLC $102.41 6 $0 (2018)
GlaxoSmithKline, LLC. $80.71 5 $0 (2023)
Mallinckrodt Hospital Products Inc. $68.86 3 $0 (2023)
Aurinia Pharma U.S., Inc. $65.70 4 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $150.19 8 AstraZeneca Pharmaceuticals LP ($96.95)
2023 $393.74 21 Bayer Healthcare Pharmaceuticals Inc. ($88.94)
2022 $214.94 13 AstraZeneca Pharmaceuticals LP ($61.05)
2021 $169.04 11 GlaxoSmithKline, LLC. ($65.64)
2020 $82.74 6 Relypsa, Inc. ($26.78)
2019 $353.62 22 OPKO Pharmaceuticals, LLC ($89.33)
2018 $250.38 17 Relypsa, Inc. ($78.41)
2017 $240.41 16 Mallinckrodt LLC ($70.94)

All Payment Transactions

114 individual payment records from CMS Open Payments — Page 5 of 5

Date Company Product Nature Form Amount Type
09/18/2017 Genentech USA, Inc. Rituxan (Biological) Food and Beverage In-kind items and services $13.47 General
Category: BioOncology/Immunology
08/07/2017 Mallinckrodt LLC ACTHAR (Biological) Food and Beverage In-kind items and services $21.53 General
Category: AUTOIMMUNE AND RARE DISEASE
08/03/2017 Amgen Inc. Sensipar (Drug) Food and Beverage In-kind items and services $17.43 General
Category: Nephrology
06/27/2017 OPKO Pharmaceuticals, LLC Rayaldee (Drug) Food and Beverage In-kind items and services $14.54 General
Category: Hyperparathyroidism
05/26/2017 Otsuka America Pharmaceutical, Inc. SAMSCA (Drug) Food and Beverage In-kind items and services $14.73 General
Category: NEPHROLOGY
05/03/2017 Mallinckrodt LLC ACTHAR (Biological) Food and Beverage In-kind items and services $16.13 General
Category: AUTOIMMUNE AND RARE DISEASE
04/13/2017 Otsuka America Pharmaceutical, Inc. SAMSCA (Drug) Food and Beverage In-kind items and services $15.00 General
Category: NEPHROLOGY
03/31/2017 Mallinckrodt LLC ACTHAR (Biological) Food and Beverage In-kind items and services $16.01 General
Category: AUTOIMMUNE AND RARE DISEASE
03/22/2017 Mallinckrodt LLC ACTHAR (Biological) Food and Beverage In-kind items and services $17.27 General
Category: AUTOIMMUNE AND RARE DISEASE
03/09/2017 Amgen Inc. Parsabiv (Biological), Sensipar Food and Beverage In-kind items and services $16.51 General
Category: Nephrology
03/08/2017 Relypsa, Inc. Veltassa (Drug) Food and Beverage In-kind items and services $11.07 General
Category: Hyperkalemia
01/25/2017 Otsuka America Pharmaceutical, Inc. SAMSCA (Drug) Food and Beverage In-kind items and services $12.11 General
Category: NEPHROLOGY
01/24/2017 Takeda Pharmaceuticals America, Inc. Uloric (Drug) Food and Beverage In-kind items and services $14.31 General
Category: Gout/Rheumatology
01/17/2017 Relypsa, Inc. Veltassa (Drug) Food and Beverage In-kind items and services $12.14 General
Category: Hyperkalemia

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 43 6,268 9,687 $2.1M $295,587
2022 43 5,952 9,976 $969,699 $264,876
2021 42 6,469 13,075 $1.1M $314,624
2020 42 6,486 14,205 $1.3M $352,014
Total Patients
25,175
Total Services
46,943
Medicare Billing
$1.2M
Procedure Codes
170

All Medicare Procedures & Services

170 procedure records from CMS Medicare Utilization — Page 1 of 7

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
90960 Dialysis services, 4 or more physician visits per month (20 years or older) Office 2023 29 207 $405,637 $54,449 13.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 455 591 $414,917 $50,409 12.1%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 185 509 $336,581 $45,674 13.6%
83970 Parathormone (parathyroid hormone) level Office 2023 371 517 $128,051 $20,768 16.2%
82306 Vitamin d-3 level Office 2023 298 394 $69,974 $11,352 16.2%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 70 71 $68,441 $9,045 13.2%
99490 Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month Office 2023 44 196 $67,397 $9,025 13.4%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 87 138 $60,643 $8,313 13.7%
82610 Cystatin c (enzyme inhibitor) level Office 2023 319 421 $46,782 $7,575 16.2%
99457 Management using the results of remote vital sign monitoring per calendar month, first 20 minutes Office 2023 47 197 $52,244 $6,986 13.4%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 58 58 $52,986 $6,562 12.4%
99454 Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days Office 2023 38 161 $42,137 $5,669 13.5%
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count Office 2023 482 671 $31,282 $5,055 16.2%
99291 Critical care, first 30-74 minutes Facility 2023 26 32 $37,834 $4,928 13.0%
36415 Insertion of needle into vein for collection of blood sample Office 2023 397 577 $10,386 $4,832 46.5%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 33 38 $37,454 $4,679 12.5%
G0444 Annual depression screening, 5 to 15 minutes Office 2023 256 256 $25,682 $4,325 16.8%
90961 Dialysis services, 2-3 physician visits per month (20 years or older) Office 2023 14 18 $29,277 $4,013 13.7%
82043 Urine microalbumin (protein) level Office 2023 478 670 $19,802 $3,761 19.0%
80069 Kidney function blood test panel Office 2023 315 438 $22,811 $3,704 16.2%
80053 Blood test, comprehensive group of blood chemicals Office 2023 289 355 $22,493 $3,637 16.2%
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units Office 2023 14 580 $28,710 $3,534 12.3%
82570 Creatinine level to test for kidney function or muscle injury Office 2023 469 650 $20,202 $3,275 16.2%
90935 Hemodialysis procedure with physician evaluation Facility 2023 22 38 $15,119 $2,072 13.7%
84550 Uric acid level, blood Office 2023 346 458 $12,421 $2,013 16.2%

About Dr. Stuart Ginther, M.D

Dr. Stuart Ginther, M.D is a Nephrology healthcare provider based in Chattanooga, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1194776799.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stuart Ginther, M.D has received a total of $1,855 in payments from pharmaceutical and medical device companies, with $150.19 received in 2024. These payments were reported across 114 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($1,793).

As a Medicare-enrolled provider, Ginther has provided services to 25,175 Medicare beneficiaries, totaling 46,943 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 170 distinct procedure/service records.

Practice Information

  • Specialty Nephrology
  • Other Specialties Nephrology
  • Location Chattanooga, TN
  • Active Since 05/16/2006
  • Last Updated 05/28/2010
  • Taxonomy Code 207RN0300X
  • Entity Type Individual
  • NPI Number 1194776799

Products in Payments

  • FARXIGA (Drug) $221.14
  • Veltassa (Drug) $189.16
  • ACTHAR (Biological) $171.27
  • SAMSCA (Drug) $170.52
  • JYNARQUE (Drug) $165.83
  • Rayaldee (Drug) $151.71
  • Kerendia (Drug) $106.22
  • BENLYSTA (Biological) $80.71
  • LUPKYNIS (Drug) $65.70
  • LOKELMA (Drug) $62.61
  • RAYALDEE (Drug) $58.30
  • Parsabiv (Biological) $49.55
  • ULTOMIRIS (Biological) $34.76
  • Parsabiv (Drug) $33.48
  • Edarbi (Drug) $30.67
  • Velphoro (Drug) $29.51
  • Rituxan (Biological) $29.45
  • TAVNEOS (Drug) $29.03
  • KRYSTEXXA (Drug) $18.62
  • Sensipar (Drug) $17.43

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Nephrology Doctors in Chattanooga